[Pain relief during and after surgical procedures : Results of an Austria-wide patient survey on postoperative pain and perioperative pain management]. / Schmerzversorgung bei chirurgischen Eingriffen : Ergebnisse einer österreichweiten Patientenbefragung zur postoperativen Schmerzsituation und zum perioperativen Schmerzmanagement.

BACKGROUND: Pain after surgery, especially on the first postoperative day, results in longer hospital stays, increased complication rates and may also cause a higher risk of pain chronification. However, the expected intensity of pain is often misjudged and therefore not adequately treated. METHODOLOGY: An Austria-wide patient survey on the pain situation on the first postoperative day and on the quality of perioperative pain management was carried out on a voluntary and anonymous basis. RESULTS: Regarding the intensity of pain a clear gender difference could be observed. Women were more prone to more severe pain than men across all age groups. This difference was most pronounced in the younger age groups (18-40 years) and in those patients showing the highest pain scores. Treatment satisfaction was correlated (high significance) with pain intensity on exercise (p < 0.01), maximum pain (p < 0.01), least pain (<0.01) and frequency of postoperative pain assessment. DISCUSSION: The risk of postoperative pain can be reduced by optimal care structures. Since patients treated in optimal care structures had significantly lower pain scores on exercise and with respect to maximum pain, the investment in the optimization of such resources should be carefully planned. Special attention should be paid to postoperative pain management in women, especially in younger female patients.

New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.

Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population. The prevalence is reported to be 1.2-1.4% in several population-based epidemiological studies. Currently 25-30 million people worldwide are blind due to AMD. With the aging world population it is bound to increase significantly, and could become a significant public health problem in next two decades, with serious socio-economic implications. Several strategies are today available to treat the wet form of AMD, which is responsible for significant visual loss. These were until recently confined to laser photocoagulation, and subretinal surgery, but today two other modalities, namely, radiation and photodynamic therapy, are available. These treatment modalities however, are aimed at preservation of vision only, and not at reversing the process of the disease. Further research on antiangiogenic drugs and gene therapy could significantly help AMD patients.